Nigratine as dual inhibitor of necroptosis and ferroptosis regulated cell death - Archive ouverte HAL
Article Dans Une Revue Scientific Reports Année : 2022

Nigratine as dual inhibitor of necroptosis and ferroptosis regulated cell death

Morgane Rousselot

Résumé

Nigratine (also known as 6E11), a flavanone derivative of a plant natural product, was characterized as highly specific non-ATP competitive inhibitor of RIPK1 kinase, one of the key components of necroptotic cell death signaling. We show here that nigratine inhibited both necroptosis (induced by Tumor Necrosis Factor-α) and ferroptosis (induced by the small molecules glutamate, erastin, RSL3 or cumene hydroperoxide) with EC50 in the µM range. Taken together, our data showed that nigratine is a dual inhibitor of necroptosis and ferroptosis cell death pathways. These findings open potential new therapeutic avenues for treating complex necrosis-related diseases.
Fichier principal
Vignette du fichier
2022_antibiotics_Caputo.pdf (2.1 Mo) Télécharger le fichier
Origine Publication financée par une institution
Licence

Dates et versions

hal-04835337 , version 1 (13-12-2024)

Licence

Identifiants

Citer

Claire Delehouzé, Arnaud Comte, Stephen Adonai Leon-Icaza, Céline Cougoule, Marcelle Hauteville, et al.. Nigratine as dual inhibitor of necroptosis and ferroptosis regulated cell death. Scientific Reports, 2022, 12 (1), pp.5118. ⟨10.1038/s41598-022-09019-w⟩. ⟨hal-04835337⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More